DTCAX
Price
$19.27
Change
+$0.07 (+0.36%)
Updated
Dec 24 closing price
Net Assets
504.61M
VTSMX
Price
$165.40
Change
+$0.51 (+0.31%)
Updated
Dec 24 closing price
Net Assets
2.06T
Interact to see
Advertisement

DTCAX vs VTSMX

Header iconDTCAX vs VTSMX Comparison
Open Charts DTCAX vs VTSMXBanner chart's image
BNY Mellon Sust US Equity A
Price$19.27
Change+$0.07 (+0.36%)
VolumeN/A
Net Assets504.61M
Vanguard Total Stock Mkt Idx I
Price$165.40
Change+$0.51 (+0.31%)
VolumeN/A
Net Assets2.06T
DTCAX vs VTSMX Comparison Chart in %
View a ticker or compare two or three
VS
DTCAX vs. VTSMX commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTCAX is a StrongBuy and VTSMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 2.06T vs. DTCAX (505M). VTSMX pays higher dividends than DTCAX: VTSMX (1.02) vs DTCAX (0.14). DTCAX was incepted earlier than VTSMX: DTCAX (26 years) vs VTSMX (34 years). DTCAX (0.98) is less costly to investors than VTSMX (0.14). DTCAX is a more actively managed with annual turnover of: 27.23 vs. VTSMX (2.00). DTCAX has a lower initial minimum investment than VTSMX: DTCAX (1000) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 14.42 vs. DTCAX (2.66). VTSMX return over 5 years is better than : 76.81 vs. DTCAX (24.04).
DTCAXVTSMXDTCAX / VTSMX
Total Expense Ratio0.950.14679%
Annual Report Gross Expense Ratio0.980.14700%
Fund Existence26 years34 years-
Gain YTD5.47317.37731%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets505M2.06T0%
Annual Yield % from dividends0.141.0214%
Returns for 1 year2.6614.4218%
Returns for 3 years46.9078.0060%
Returns for 5 years24.0476.8131%
Returns for 10 years69.61234.9630%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HALO68.410.05
+0.07%
Halozyme Therapeutics
COLAU10.51N/A
N/A
Columbus Acquisition Corp
KMTS27.52-0.03
-0.11%
Kestra Medical Technologies, Ltd.
DAVA6.53-0.01
-0.15%
Endava plc
CVU3.65-0.02
-0.54%
CPI Aerostructures